Real-world data and real-world evidence are related terms used in the field of healthcare and clinical research. While they share some similarities, they have distinct meanings and applications:
In summary, RWD refers to the raw data collected from real-world sources, while RWE is the evidence generated from analyzing and interpreting that data. RWE helps bridge the gap between controlled clinical trial settings and real-world clinical practice, providing valuable insights into the effectiveness and safety of healthcare interventions in diverse patient populations and settings.
Pharmaceutical companies use real-world data (RWD) in several ways to inform various aspects of their drug development and commercialization processes. Here are some common applications of RWD in the pharmaceutical industry:
It’s worth noting that the use of RWD by pharmaceutical companies must adhere to strict privacy and data protection regulations, ensuring patient confidentiality and maintaining data integrity throughout the process.
Obtaining real-world data (RWD) involves accessing and collecting data from various sources outside of controlled clinical trial settings. Here are some common methods to obtain RWD:
Look through our white papers, case studies and other resources to find out how our research drives innovation and results.